Brief: CorMedix Announces Strategic Minority Investment in Talphera
Sept 8 (Reuters) - CorMedix Inc CRMD.O: CORMEDIX ANNOUNCES STRATEGIC MINORITY INVESTMENT IN TALPHERA CORMEDIX INC - ANNOUNCES $5 MILLION INVESTMENT IN TALPHERA CORMEDIX INC - TALPHERA TO USE PROCEEDS FOR PHASE 3 STUDY FOR NIYAD AND FOR PRE-LAUNCH PREPARATIONS CORMEDIX INC - GRANTED EXCLUSIVE NEGOTIATION RIGHTS FOR TALPHERA Source text: ID:nGNX84SPgH Further company coverage: CRMD.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Talphera
See all newsTalphera Inc reports results for the quarter ended June 30 - Earnings Summary
Talphera Inc expected to post a loss of 7 cents a share - Earnings Preview
Talphera Q1 net loss narrows as costs rise on higher development spending
Talphera Q4 net loss widens as operating expenses rise
Brief: Talphera Announces 50% Enrollment Milestone In Ongoing Nephro-Crrt Registrational Trial